Description:

AbbVie Inc. (ABBV), listed on the New York Stock Exchange (NYSE), is a multinational pharmaceutical company that specializes in the research, development, and manufacturing of innovative treatments for various diseases. As one of the largest independent pharmaceutical companies in the world, AbbVie has a diverse portfolio of established and emerging products, including immunology, oncology, and neuroscience therapies. The company's flagship product, Humira, is a highly successful biologic medication used to treat autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease, generating significant revenue for the company. With a strong focus on research and development, AbbVie continues to expand its pipeline of potential treatments, positioning itself for long-term growth and success in the highly competitive pharmaceutical industry.

Data:

Yields: